课题基金 / 基金详情

Genomic Scanning for Generic and Epigenetic Alterations in head and neck cancer

Genomic Scanning for Generic and Epigenetic Alterations in head and neck cancer
头颈癌的一般和表观遗传改变的基因组扫描
批准号:
7795936
负责人:
CHRISTOPH PLASS
金额:
$25.93万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2012-01-31

项目摘要

项目成果

CHRISTOPH PLASS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):这是一个竞争性的续期资助“基因扫描的表观遗传学和遗传改变的头颈癌”。之前的资助已经成功完成,并产生了大量数据,描述了头颈部鳞状细胞癌(HNSCC)中DMA甲基化和DMA扩增的改变。其中一个新基因(转录因子21或TCF21)位于染色体6q23-24上,是HNSCC和其他恶性肿瘤中经常缺失的区域,具有肿瘤抑制功能和转移抑制活性。TCF21是人类肿瘤中DNA甲基化改变的常见靶点,并且被DMA甲基化在转录水平上沉默。我们提供的初步数据支持我们的假设,即TCF21是一个新的肿瘤/转移抑制基因。为了解决这一假设,我们提出了三个具体目标。(1)在目标1中,我们将研究TCF21和可能的选择性剪接形式在各种正常组织和癌细胞系中的表达模式,并详细评估DMA甲基化如何导致DMA沉默。接下来,我们将评估TCF21在HNSCC和肺癌中的突变谱,以确定TCF21沉默在每种肿瘤类型中的重要性。(2)在目标2中,我们提出了一些实验,这些实验将有助于了解TCF21在肿瘤发生中的作用,并结合表达阵列、芯片、酵母双杂交和荧光素酶分析来确定不同组织的结合伙伴和靶基因。(3)在目标3中,我们将利用小鼠模型进一步研究TCF21的作用。我们正在计划裸鼠的致瘤性和转移实验,我们提议用TCF21杂合基因敲除小鼠进行致癌实验;并将在口腔癌和肺癌的小鼠模型中研究TCF21及其下游靶点。
英文摘要
DESCRIPTION (provided by applicant): This is a competitive renewal of grant "Genomic Scanning for Epigenetic and Genetic alterations in Head and neck cancer". The previous grant has been successfully completed and resulted in a wealth of data describing altered DMA methylation and DMA amplification in head and neck squamous cell carcinoma (HNSCC). One of the novel genes (transcription factor 21 orTCF21), identified on chromosome 6q23-24, a region frequently lost in HNSCC, as well as other malignancies has tumor suppressor function, as well as metastasis suppressing activity. TCF21 is a frequent target for altered DMA methylation in human tumors and is transcriptionally silenced by DMA methylation. We provide preliminary data supporting our hypothesis that TCF21 is a novel tumor/metastasis suppressor gene. To address this hypothesis, we propose three specific aims. (1) In aim 1 we will investigate expression patterns of TCF21 and possible alternative splice forms in various normal tissues and cancer cell lines and evaluate in detail how DMA methylation contributes to DMA silencing. We will next evaluate the mutational spectrum of TCF21 in HNSCC and lung cancer to determine the importance of TCF21 silencing in each tumor type. (2) In aim 2 we propose experiments that will help to understand how TCF21 contributes to tumorgenesis and identify binding partners and target genes specific for different tissues using a combination of expression array, ChIP, yeast two hybrid and luciferase assays. (3) In aim 3 we will utilize mouse models to further investigate the role of TCF21. We are planning nude mouse tumorigenicity and metastasis assays, we are proposing a carcinogenesis experiment with Tcf21 heterozygous knock out mice; and will investigate Tcf21 and downstream targets in a mouse model for oral cavity carcinogenesis and lung carcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genotyping and Sequencing
  • 批准号:
    7613088
  • 项目类别:
  • 资助金额:
    $9.16万
  • 财政年份:
    2005
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
Identification of Methylated Genes in Chronic Lymphocytic Leukemia
  • 批准号:
    6986001
  • 项目类别:
  • 资助金额:
    $21.76万
  • 财政年份:
    2005
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
DNA methylation as a diagnostic marker in AML
  • 批准号:
    6998912
  • 项目类别:
  • 资助金额:
    $28.84万
  • 财政年份:
    2002
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
DNA methylation as a diagnostic marker in AML
  • 批准号:
    6417420
  • 项目类别:
  • 资助金额:
    $29.49万
  • 财政年份:
    2002
  • 负责人:
    CHRISTOPH PLASS
  • 依托单位:
海外基金